Doxycycline for STI Prevention: Evidence and Current Research
Very high STI prevalence is being observed globally. Doxycycline post-exposure prophylaxis (dPEP) has been proposed as an STI prevention strategy to reduce chlamydia, syphilis, and possibly gonorrhea, and trials are ongoing among cisgender gay and bisexual men as well as African cisgender women. Join us to hear the latest scientific data and discuss implications for policy and program.
Speakers:
Dr. Connie Celum, University of Washington
David C. Harvey, National Coalition of STD Directors
Dr. Victor Omollo, Kenya Medical Research Institute
Private Sector Delivery Opportunities for the Dual Prevention Pill (DPP)
Lessons from family planning (FP) for the introduction of multi-purpose prevention technologies (MPTs)
The Dual Prevention Pill (DPP) is a daily pill being developed for simultaneous pregnancy and HIV prevention. With anticipated rollout of the DPP just two years away, planning for where to introduce the DPP in the private sector will be critical for ensuring access, but will hinge on where PrEP delivery is already permitted.
In this webinar, we shared new findings on private sector opportunities for the DPP in Kenya, South Africa and Zimbabwe. We explored lessons and successes from the FP experience to identify how FP/SRH stakeholders can help pave the way for smooth introduction of MPTs like the DPP in private sector channels.
PrEPWatch is a one-stop online clearinghouse for resources and information to help the global community effectively deliver every proven method of PrEP to everyone who needs it. This webinar explored the newly relaunched site and walked through some of the latest features including better-than-ever curation, navigation, and search. We heard from leading advocates on what’s in the pipeline for prevention products and trends happening in PrEP uptake and delivery.
A Conversation with The London Patient: The second known person cured of HIV
Join us for a conversation with The London Patient, Adam Castillejo — only the second person cured of HIV. He will share his experience with the procedure that ultimately eradicated HIV from his body, why people should be hopeful about the state of the research, and what his life is like after HIV. Attendees will be able to ask questions and take photos with Adam after the event.
Africa Health R&D Week 2022 is designed to recognize achievements and step up advocacy for sustainable financing of health R&D through domestic resource mobilization (DRM) in Africa. The week contains a series of informative, networking, and motivational events for advocates, media, policymakers, program implementors, researchers, and funders to bring clarity to key issues and trends of DRM for health R&D on the continent. The content and programming of Africa Health R&D Week is informed by the various coalitions advocating for DRM for health.
Speakers:
Ogwell Ouma, Acting Director of Africa CDC
Parfait Uwaliraye, Ministry of Health, Rwanda
Jason Braganza, AFRODAD
Frances Illka, Palladium
Agnes Binagwaho, University of Global Health Equity
Much Accomplished, Much to Do: A Conversation Looking Back & Looking Ahead with Tony Fauci
AVAC Executive Director Mitchell Warren spoke with NIAID Director, Anthony Fauci to discuss all that’s been accomplished in the HIV and COVID-19 responses over the years, what’s ahead, and what the future looks like for NIAID, for Dr. Fauci and for pandemic preparedness.
HIV, COVID-19, and Gender Inequality: A Call to Action
Many of the drivers of gender inequality in the HIV epidemic are the same as those driving inequality in the COVID-19 pandemic. During the COVID-19 pandemic, women and girls are at heightened risk of domestic violence and inadequate access of essential health care including HIV prevention and sexual and reproductive health services. To better prepare for the future, during this conversation we will discuss the imperative to address the underlying social factors like gender inequality that exacerbate these pandemics.
Thursday, December 8 at 15:00 PM EAT / 14:00 PM SAST/ 13:00 PM WAT / 8:00 AM EDT marks the launch of the inaugural Domestic Resource Mobilization (DRM) Learning Collaborative. The collaborative will be a facilitated virtual space that brings together global health advocates, civil society organizations and other key stakeholders from Africa to engage in peer-to-peer learning and collaboration. Topics will include local investments in health including HIV, pandemic preparedness, research and development (R&D), and use the time to explore opportunities and challenges, and frame what questions must be answered to develop a unifying advocacy agenda.
The 2022 Global Health Landscape Symposium (GHLS2022) convened from December 7-8 asking the question “How do we meet this moment?” three years after an ongoing pandemic and three years since the Global Health Community last met in person. The agenda, videos and a partner toolkit are available here.
Avac Event
CROI 2023
The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place from February 19 through February 22 in Seattle, Washington. This was the first in-person CROI since 2019, but also included the virtual component honed during COVID, with 3,000+ individuals registered to participate in-person and 500+ online.
Below are highlights from the conference:
Follow Along
Conference coverage was available via aidsmap, AVAC on Twitter at @hivpxresearch and the conference hashtag #CROI2023. Conference press conferences are posted here.
AVAC, the CROI Community Liaison Subcommittees, European AIDS Treatment Group, and other partners hosted virtual Margarita Breakfast Clubs (MBCs) open to all.
Monday, February 20 Arrested Development: Discontinuation of the MOSAICO Trial, its Legacy and Expectations for HIV Vaccine Research Recording / Slides / Summary
Tuesday, February 21 Moving Forward: Upcoming Strategies on STI Prevention Recording / Slides / Summary
Wednesday, February 22 The Data Gap: Filling in the Missing Perspectives on Women and Children in HIV Research Recording / Resources / Summary
